Best Agrolife (539660) Q2 24/25 earnings summary

Executive summary

• Q2 FY25 delivered strong profitability and margin expansion, driven by a strategic focus on branded products, innovation, and R&D, despite an 8% year-over-year revenue decline due to lower institutional sales, price reductions, and weather impacts.

• Secured three key patents in H1 FY25, reinforcing leadership in crop protection and expanding the innovative product portfolio.

• Operating cash flow improved significantly to INR 125 crore (₹1,251 million) in H1 FY25 from INR 5 crore (₹50.9 million) in H1 FY24, aided by effective working capital management and full liquidation of high-cost inventory.

• Transformation towards a B2C, brand-led business model, with SAP implementation enhancing operational efficiency and channel management.

• Above-average monsoon and improved reservoir levels support a positive outlook for the Rabi season and agricultural demand.

Financial highlights

• Q2 FY25 revenue from operations: INR 747 crore (₹7,466 million), down 8% YoY; H1 FY25 revenue: INR 1,266 crore (₹12,659 million), down from INR 1,423 crore in H1 FY24.

• Q2 FY25 EBITDA: INR 147 crore (₹1,471 million), margin 19–20%, up from 18% YoY; Q2 PAT: INR 95 crore (₹947 million), margin 12.7–13%, nearly flat YoY.

• H1 FY25 EBITDA: INR 202 crore, margin 16%; H1 PAT: INR 116 crore, margin 9%, both down YoY.

• Branded business contributed 65% of Q2 FY25 revenue, with branded sales volume up 35% YoY; institutional sales down 41%.

• Operating cash flow improved to INR 125 crore (₹1,251 million) in H1 FY25 from INR 5 crore (₹50.9 million) in H1 FY24.

Outlook and guidance

• FY25 revenue expected to exceed INR 2,000 crore, with at least 15% top-line growth and 16% EBITDA margin; FY26 top-line growth guided at 20%.

• Expects FY25 revenue growth of 15–20% and EBITDA margin of 15–17%.

• Strong Rabi season anticipated due to favorable reservoir levels and delayed monsoon, supporting higher sales in Q3 and Q4.

• Plans to launch new patented products, including 'Shot Down' herbicide and additional insecticides in Q3 and Q4 FY25, with a pipeline of 2–3 new patented products per year.

• Focus on ramping up distribution, branded business, and improving cash flows and working capital cycle.